Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(1.71)
# 2,689
Out of 4,412 analysts
47
Total ratings
31.82%
Success rate
-9.62%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUGX Augmedix | Upgrades: Outperform | $4.5 → $5 | $2.85 | +75.44% | 3 | Apr 9, 2024 | |
| DOCS Doximity | Maintains: In-Line | $30 | $23.82 | +25.94% | 3 | Apr 2, 2024 | |
| PRVA Privia Health Group | Maintains: Outperform | $26 → $25 | $18.26 | +36.91% | 2 | Feb 28, 2024 | |
| AGL agilon health | Maintains: In-Line | $7 → $6 | $5.00 | +20.00% | 2 | Feb 28, 2024 | |
| RCM R1 RCM | Downgrades: In-Line | $12 → $16 | $11.90 | +34.45% | 2 | Feb 28, 2024 | |
| HCAT Health Catalyst | Maintains: Outperform | $11 → $10 | $6.03 | +65.84% | 3 | Feb 23, 2024 | |
| IQV IQVIA Holdings | Maintains: Market Outperform | $255 → $265 | $234.88 | +12.82% | 1 | Feb 15, 2024 | |
| LH Laboratory Corporation of America Holdings | Initiates: In-Line | $240 | $198.40 | +20.97% | 1 | Feb 9, 2024 | |
| FTRE Fortrea Holdings | Upgrades: Outperform | $32 → $36 | $36.35 | -0.96% | 2 | Dec 1, 2023 | |
| CVS CVS Health | Upgrades: Outperform | $81 → $83 | $67.18 | +23.55% | 3 | Sep 19, 2023 | |
| CAH Cardinal Health | Downgrades: In-Line | $100 | $103.21 | -3.11% | 2 | Jul 10, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: In-Line | $32 | $17.70 | +80.79% | 9 | Jun 27, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $230 → $375 | $309.02 | +21.35% | 6 | Feb 2, 2023 | |
| DGX Quest Diagnostics | Initiates: In-Line | $159 | $134.26 | +18.43% | 1 | Jan 23, 2023 | |
| GOCO GoHealth | Maintains: In-Line | $68 → $26 | $10.15 | +158.62% | 3 | Mar 16, 2022 | |
| EHTH eHealth | Downgrades: In-Line | $35 → $15 | $4.53 | +231.13% | 2 | Mar 2, 2022 | |
| SLQT SelectQuote | Downgrades: In-Line | $11 | $1.61 | +583.23% | 1 | Jan 4, 2022 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | n/a | $30.57 | - | 1 | May 27, 2020 |
Augmedix
Apr 9, 2024
Upgrades: Outperform
Price Target: $4.5 → $5
Current: $2.85
Upside: +75.44%
Doximity
Apr 2, 2024
Maintains: In-Line
Price Target: $30
Current: $23.82
Upside: +25.94%
Privia Health Group
Feb 28, 2024
Maintains: Outperform
Price Target: $26 → $25
Current: $18.26
Upside: +36.91%
agilon health
Feb 28, 2024
Maintains: In-Line
Price Target: $7 → $6
Current: $5.00
Upside: +20.00%
R1 RCM
Feb 28, 2024
Downgrades: In-Line
Price Target: $12 → $16
Current: $11.90
Upside: +34.45%
Health Catalyst
Feb 23, 2024
Maintains: Outperform
Price Target: $11 → $10
Current: $6.03
Upside: +65.84%
IQVIA Holdings
Feb 15, 2024
Maintains: Market Outperform
Price Target: $255 → $265
Current: $234.88
Upside: +12.82%
Laboratory Corporation of America Holdings
Feb 9, 2024
Initiates: In-Line
Price Target: $240
Current: $198.40
Upside: +20.97%
Fortrea Holdings
Dec 1, 2023
Upgrades: Outperform
Price Target: $32 → $36
Current: $36.35
Upside: -0.96%
CVS Health
Sep 19, 2023
Upgrades: Outperform
Price Target: $81 → $83
Current: $67.18
Upside: +23.55%
Cardinal Health
Jul 10, 2023
Downgrades: In-Line
Price Target: $100
Current: $103.21
Upside: -3.11%
Walgreens Boots Alliance
Jun 27, 2023
Maintains: In-Line
Price Target: $32
Current: $17.70
Upside: +80.79%
Align Technology
Feb 2, 2023
Maintains: Outperform
Price Target: $230 → $375
Current: $309.02
Upside: +21.35%
Quest Diagnostics
Jan 23, 2023
Initiates: In-Line
Price Target: $159
Current: $134.26
Upside: +18.43%
GoHealth
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $10.15
Upside: +158.62%
eHealth
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $4.53
Upside: +231.13%
SelectQuote
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $1.61
Upside: +583.23%
DENTSPLY SIRONA
May 27, 2020
Upgrades: Outperform
Price Target: n/a
Current: $30.57
Upside: -